Latest Breaking News On - Azitra inc - Page 1 : comparemela.com

Azitra (NYSEAMERICAN:AZTR) Trading Down 6 3%

Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) shares traded down 6.3% on Tuesday . The stock traded as low as $0.17 and last traded at $0.17. 719,255 shares changed hands during mid-day trading, a decline of 8% from the average session volume of 784,450 shares. The stock had previously closed at $0.18. Azitra Stock Performance […]

Azitra incAzitra company profileExchange commissionWarberg asset managementGet free reportAsset managementFree reportAzitra daily

Azitra, Inc Announces Presentation at the 2024 BIO International Convention

Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that management will present at the 2024 BIO.

United statesSan diegoSan diego convention centerTravis whitfillInternational conventionAzitra incSan diego conventionChief operating officerOne partneringPrivate securities litigation reform act

Azitra, Inc Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

ATR-04 is in development for epidermal growth factor receptor inhibitor -induced dermal toxicity, which affects approximately 150,000 patients in the US Reduces methicillin-resistant S. aureus by.

United statesTravis whitfillSociety of investigative dermatologyAzitra incInvestigative dermatologyInvestigational new drugPrivate securities litigation reform act

Azitra, Inc (AZTR) Presents Positive Preclinical Data from ATR-04

Azitra, Inc (AZTR) Presents Positive Preclinical Data from ATR-04
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTravis whitfillSociety of investigative dermatologyAzitra incInvestigative dermatologyInvestigational new drug

Azitra, Inc Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

Azitra, Inc Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesTravis whitfillAmerican society of geneAzitra incStaphylococcus epidermidisProtein delivery systemTreating skinStrain expressingAmerican societyCell therapyPrivate securities litigation reform act